Morgan Stanley Portfolio holdings
Morgan Stanley, founded in 1935 by Henry Sturgis Morgan and Harold Stanley as a spin-off from J.P. Morgan & Co., is a leading global financial services firm headquartered in New York City. Initially focused on investment banking, it has evolved into a diversified powerhouse offering wealth management, institutional securities, and asset management services, catering to corporations, governments, institutions, and high-net-worth individuals. With a strong presence in mergers and acquisitions, underwriting, and trading, Morgan Stanley manages billions in assets and is known for its sophisticated financial advisory services. The firm has adapted to modern markets by expanding its digital offerings and wealth management division, notably through its 2020 acquisition of E*TRADE, solidifying its position as a Wall Street titan.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
XYZ
Block Inc
XYZ
|
+$1.53B |
| 2 |
Procter & Gamble
PG
|
+$1.01B |
| 3 |
iShares iBoxx $ High Yield Corporate Bond ETF
HYG
|
+$684M |
| 4 |
Zoom
ZM
|
+$534M |
| 5 |
Chewy
CHWY
|
+$491M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$5.07B |
| 2 |
ServiceNow
NOW
|
+$874M |
| 3 |
State Street Financial Select Sector SPDR ETF
XLF
|
+$776M |
| 4 |
Invesco QQQ Trust
QQQ
|
+$767M |
| 5 |
Apple
AAPL
|
+$719M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 19.32% |
| 2 | Healthcare | 10.4% |
| 3 | Consumer Discretionary | 8.1% |
| 4 | Communication Services | 7.82% |
| 5 | Financials | 7.44% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
351
Kinder Morgan
KMI
$70.5B
| $201M | 0.04% |
13,270,689
+673,176
| +5% | +$10.2M |
|
352
Advanced Micro Devices
AMD
$791B
| $200M | 0.04% |
3,803,955
+295,871
| +8% | +$15.7M |
|
353
Vertex Pharmaceuticals
VRTX
$122B
| $200M | 0.04% |
688,918
+13,423
| +2% | +$3.64M |
|
354
State Street SPDR Nuveen ICE Municipal Bond ETF
TFI
$3.06B
| $199M | 0.04% |
3,858,885
-42,251
| -1% | -$2.15M |
|
355
AstraZeneca
AZN
$266B
| $198M | 0.04% |
1,875,258
+760,808
| +68% | +$78.6M |
|
|
CYBR
356
DELISTED
CyberArk
CYBR
| $198M | 0.04% |
1,995,966
+311,821
| +19% | +$30.3M |
|
357
Truist Financial
TFC
$63.5B
| $198M | 0.04% |
5,262,153
+1,956,641
| +59% | +$70.5M |
|
358
SL Green Realty
SLG
$3.81B
| $197M | 0.04% |
4,134,556
-208,602
| -5% | -$9.58M |
|
359
Progressive
PGR
$124B
| $197M | 0.04% |
2,460,638
+568,674
| +30% | +$44.4M |
|
360
Hartford Multifactor Developed Markets ex-US ETF
RODM
$1.63B
| $195M | 0.04% |
7,930,980
-2,340,382
| -23% | -$55.5M |
|
361
Booking.com
BKNG
$150B
| $195M | 0.04% |
3,059,300
+93,975
| +3% | +$5.72M |
|
362
iShares S&P Small-Cap 600 Value ETF
IJS
$8.12B
| $195M | 0.04% |
3,237,020
+99,760
| +3% | +$5.59M |
|
363
ON Semiconductor
ON
$32.6B
| $194M | 0.04% |
9,790,056
+7,211,983
| +280% | +$118M |
|
364
PNC Financial Services
PNC
$99.2B
| $192M | 0.04% |
1,820,605
+454,521
| +33% | +$47.9M |
|
|
MRSH
365
Marsh
MRSH
$91.4B
| $191M | 0.04% |
1,782,723
+38,600
| +2% | +$3.91M |
|
366
VanEck Morningstar Wide Moat ETF
MOAT
$11.8B
| $190M | 0.04% |
3,642,767
+232,788
| +7% | +$11.6M |
|
367
Berkshire Hathaway Class A
BRK.A
$1.1T
| $190M | 0.04% |
711
-13
| -2% | -$3.56M |
|
368
Fox Class B
FOX
$22B
| $189M | 0.04% |
7,046,520
+429,076
| +6% | +$11.4M |
|
369
Infosys
INFY
$48.4B
| $188M | 0.04% |
19,491,181
+13,508,789
| +226% | +$121M |
|
370
SBA Communications
SBAC
$19.3B
| $188M | 0.04% |
629,772
-57,914
| -8% | -$17.1M |
|
371
NYLI Hedge Multi-Strategy Tracker ETF
QAI
$1.01B
| $187M | 0.04% |
6,174,233
+765,284
| +14% | +$22.6M |
|
372
Clorox
CLX
$11.7B
| $187M | 0.04% |
853,223
+119,920
| +16% | +$24M |
|
373
ICICI Bank
IBN
$109B
| $187M | 0.04% |
20,134,770
+3,295,124
| +20% | +$29.3M |
|
|
SCHW
374
Charles Schwab
SCHW
$181B
| $187M | 0.04% |
5,531,371
+37,810
| +0.7% | +$1.35M |
|
375
Kraft Heinz
KHC
$31.3B
| $186M | 0.04% |
5,844,189
+1,038,515
| +22% | +$31.2M |
|
Similar funds
Morgan Stanley's Q2 2020 Portfolio in Review
As of Q2 2020, Morgan Stanley held 6,941 positions worth $452B, up 23% from $368B the previous quarter. Its ten largest holdings account for 17% of the portfolio.
Morgan Stanley's Q2 2020 filing shows 185 new, 3,288 increased, 2,645 reduced and 222 closed positions. Its largest new stake was Royalty Pharma: 6,205,186 shares worth $301M. The largest sale was State Street SPDR S&P 500 ETF Trust, an estimated $5.07B.
By sector, the portfolio is most concentrated in Technology at 19% of assets, up from 16% a quarter earlier, followed by Healthcare and Consumer Discretionary.
- Morgan Stanley's largest Q2 2020 buy was Royalty Pharma: 6,205,186 shares worth $301M.
- Morgan Stanley added most to Block Inc in Q2 2020, an estimated $1.53B increase.
- Morgan Stanley's biggest Q2 2020 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $5.07B.
- Morgan Stanley fully exited Allergan plc in Q2 2020, selling an estimated $487M.
- Morgan Stanley's ten largest holdings make up 17% of its $452B portfolio in Q2 2020.
- Morgan Stanley opened 185 new positions and closed 222 in Q2 2020.
- Morgan Stanley's portfolio value rose 23% quarter-over-quarter to $452B.
Based on Morgan Stanley's 13F filing for Q2 2020, filed 14 Aug 2020.